A Real-world Study on the Influencing Factors of Efficacy of Ruxolitinib Cream in Vitiligo
Recruiting
Observational Study
Vitiligo
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 12 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 170 (estimated)
- Sponsor
- Peking University Third Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Vitiligo is a common chronic autoimmune skin disease that can occur on any part of the body and severely impacts patients' quality of life. Current treatment for vitiligo primarily include topical medications, phototherapy, systemic therapy and surgical interventions, but their efficacy is limited, often failing to achieve ideal therapeutic outcomes, and are associated with a high recurrence rate.…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Age12 years or older, any gender;
2. Signed"Informed Consent Form";
3. Clinically diagnosed with non-segmental vitiligo;
4. Vitiligo area less than 10% of body surface area;
5. Agreed to discontinue all other vitiligo-related treatments from the screening visit until the fina…
Contacts